215 related articles for article (PubMed ID: 36211973)
1. Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models.
Berthold EJ; Ma-Lauer Y; Chakraborty A; von Brunn B; Hilgendorff A; Hatz R; Behr J; Hausch F; Staab-Weijnitz CA; von Brunn A
Front Cell Infect Microbiol; 2022; 12():958634. PubMed ID: 36211973
[TBL] [Abstract][Full Text] [Related]
2. Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication.
Ma-Lauer Y; Zheng Y; Malešević M; von Brunn B; Fischer G; von Brunn A
Antiviral Res; 2020 Jan; 173():104620. PubMed ID: 31634494
[TBL] [Abstract][Full Text] [Related]
3. Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir.
Carbajo-Lozoya J; Ma-Lauer Y; Malešević M; Theuerkorn M; Kahlert V; Prell E; von Brunn B; Muth D; Baumert TF; Drosten C; Fischer G; von Brunn A
Virus Res; 2014 May; 184():44-53. PubMed ID: 24566223
[TBL] [Abstract][Full Text] [Related]
4. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506.
Carbajo-Lozoya J; Müller MA; Kallies S; Thiel V; Drosten C; von Brunn A
Virus Res; 2012 Apr; 165(1):112-7. PubMed ID: 22349148
[TBL] [Abstract][Full Text] [Related]
5. Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell line.
Mamatis JE; Gallardo-Flores CE; Sangwan U; Tooley TH; Walsh T; Colpitts CC
Antiviral Res; 2023 Nov; 219():105730. PubMed ID: 37805057
[TBL] [Abstract][Full Text] [Related]
6. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts.
Göthel SF; Marahiel MA
Cell Mol Life Sci; 1999 Mar; 55(3):423-36. PubMed ID: 10228556
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
[TBL] [Abstract][Full Text] [Related]
8. [Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors].
Tian L; Liu W; Sun L
Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):605-611. PubMed ID: 32347055
[TBL] [Abstract][Full Text] [Related]
9. Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.
Gerna G; Campanini G; Rovida F; Percivalle E; Sarasini A; Marchi A; Baldanti F
J Med Virol; 2006 Jul; 78(7):938-49. PubMed ID: 16721849
[TBL] [Abstract][Full Text] [Related]
10. Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus
Sauerhering L; Kupke A; Meier L; Dietzel E; Hoppe J; Gruber AD; Gattenloehner S; Witte B; Fink L; Hofmann N; Zimmermann T; Goesmann A; Nist A; Stiewe T; Becker S; Herold S; Peteranderl C
Eur Respir J; 2020 Nov; 56(5):. PubMed ID: 32616594
[TBL] [Abstract][Full Text] [Related]
11. A proposed molecular model for the interaction of calcineurin with the cyclosporin A-cyclophilin A complex.
Ivery MT
Bioorg Med Chem; 1999 Jul; 7(7):1389-402. PubMed ID: 10465413
[TBL] [Abstract][Full Text] [Related]
12. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
[TBL] [Abstract][Full Text] [Related]
13. Cellular peptidyl-prolyl cis/trans isomerase Pin1 facilitates replication of feline coronavirus.
Tanaka Y; Amano A; Morisaki M; Sato Y; Sasaki T
Antiviral Res; 2016 Feb; 126():1-7. PubMed ID: 26675666
[TBL] [Abstract][Full Text] [Related]
14. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
[TBL] [Abstract][Full Text] [Related]
15. Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup.
Lau SKP; Lung DC; Wong EYM; Aw-Yong KL; Wong ACP; Luk HKH; Li KSM; Fung J; Chan TTY; Tang JYM; Zhu L; Yip CCY; Wong SCY; Lee RA; Tsang OTY; Yuen KY; Woo PCY
mSphere; 2021 Feb; 6(1):. PubMed ID: 33568452
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional structure and actions of immunosuppressants and their immunophilins.
Braun W; Kallen J; Mikol V; Walkinshaw MD; Wüthrich K
FASEB J; 1995 Jan; 9(1):63-72. PubMed ID: 7529736
[TBL] [Abstract][Full Text] [Related]
17. An overview on the seven pathogenic human coronaviruses.
Kesheh MM; Hosseini P; Soltani S; Zandi M
Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
19. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
Bell A; Wernli B; Franklin RM
Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
[TBL] [Abstract][Full Text] [Related]
20. A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets.
Kratzel A; Kelly JN; V'kovski P; Portmann J; Brüggemann Y; Todt D; Ebert N; Shrestha N; Plattet P; Staab-Weijnitz CA; von Brunn A; Steinmann E; Dijkman R; Zimmer G; Pfaender S; Thiel V
PLoS Biol; 2021 Dec; 19(12):e3001490. PubMed ID: 34962926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]